These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 9447945

  • 1. Lymphocyte vaccination protects prediabetic non-obese diabetic mice from developing diabetes mellitus.
    Gearon CL, Hussain MJ, Vergani D, Peakman M.
    Diabetologia; 1997 Dec; 40(12):1388-95. PubMed ID: 9447945
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Flow cytometric enumeration of mononuclear cell populations infiltrating the islets of Langerhans in prediabetic NOD mice: development of a model of autoimmune insulitis for type I diabetes.
    Jarpe AJ, Hickman MR, Anderson JT, Winter WE, Peck AB.
    Reg Immunol; 1997 Dec; 3(6):305-17. PubMed ID: 2132756
    [Abstract] [Full Text] [Related]

  • 5. BCG vaccination prevents insulin-dependent diabetes mellitus (IDDM) in NOD mice after disease acceleration with cyclophosphamide.
    Qin HY, Singh B.
    J Autoimmun; 1997 Jun; 10(3):271-8. PubMed ID: 9218754
    [Abstract] [Full Text] [Related]

  • 6. Vaccination with IA-2 autoantigen can prevent late prediabetic nonobese diabetic mice from developing diabetes mellitus.
    Guan Y, Zhang M, Li Y, Cao W, Ji M, Liu Y.
    Diabetes Res Clin Pract; 2012 Jan; 95(1):93-7. PubMed ID: 22004942
    [Abstract] [Full Text] [Related]

  • 7. [Mechanisms of human glutamic acid decarboxylase 65 DNA vaccine preventing diabetes in non-obese diabetic mice].
    Luo JH, Zhou ZG, Jiang TJ, Pei JH, Li X, He L, Sun SG.
    Zhonghua Yi Xue Za Zhi; 2004 Nov 02; 84(21):1791-5. PubMed ID: 15631776
    [Abstract] [Full Text] [Related]

  • 8. Islet-infiltrating T cell clones from non-obese diabetic mice that promote or prevent accelerated onset diabetes.
    Pankewycz O, Strom TB, Rubin-Kelley VE.
    Eur J Immunol; 1991 Apr 02; 21(4):873-9. PubMed ID: 1902177
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Induction of tolerance in murine autoimmune diabetes by transient blockade of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 pathway.
    Moriyama H, Yokono K, Amano K, Nagata M, Hasegawa Y, Okamoto N, Tsukamoto K, Miki M, Yoneda R, Yagi N, Tominaga Y, Kikutani H, Hioki K, Okumura K, Yagita H, Kasuga M.
    J Immunol; 1996 Oct 15; 157(8):3737-43. PubMed ID: 8871677
    [Abstract] [Full Text] [Related]

  • 11. IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function.
    Cameron MJ, Arreaza GA, Zucker P, Chensue SW, Strieter RM, Chakrabarti S, Delovitch TL.
    J Immunol; 1997 Nov 15; 159(10):4686-92. PubMed ID: 9366391
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Predominance of T lymphocytes in pancreatic islets and spleen of pre-diabetic non-obese diabetic (NOD) mice: a longitudinal study.
    Miyazaki A, Hanafusa T, Yamada K, Miyagawa J, Fujino-Kurihara H, Nakajima H, Nonaka K, Tarui S.
    Clin Exp Immunol; 1985 Jun 15; 60(3):622-30. PubMed ID: 3160515
    [Abstract] [Full Text] [Related]

  • 14. Protection from experimental autoimmune diabetes in the non-obese diabetic mouse with soluble interleukin-1 receptor.
    Nicoletti F, Di Marco R, Barcellini W, Magro G, Schorlemmer HU, Kurrle R, Lunetta M, Grasso S, Zaccone P, Meroni P.
    Eur J Immunol; 1994 Aug 15; 24(8):1843-7. PubMed ID: 8056041
    [Abstract] [Full Text] [Related]

  • 15. Differences in adhesion markers, activation markers, and TcR in islet infiltrating vs. peripheral lymphocytes in the NOD mouse.
    Goldrath AW, Barber L, Chen KE, Alters SE.
    J Autoimmun; 1995 Apr 15; 8(2):209-20. PubMed ID: 7612149
    [Abstract] [Full Text] [Related]

  • 16. Short administration of polyclonal anti-T cell antibody (ALS) in NOD mice with extensive insulitis prevents subsequent development of autoimmune diabetes.
    Ogawa N, Minamimura K, Kodaka T, Maki T.
    J Autoimmun; 2006 Jun 15; 26(4):225-31. PubMed ID: 16713179
    [Abstract] [Full Text] [Related]

  • 17. Potential risk of oral insulin with adjuvant for the prevention of Type I diabetes: a protocol effective in NOD mice may exacerbate disease in BB rats.
    Bellmann K, Kolb H, Rastegar S, Jee P, Scott FW.
    Diabetologia; 1998 Jul 15; 41(7):844-7. PubMed ID: 9686928
    [Abstract] [Full Text] [Related]

  • 18. [Effects of pravastatin in prevention of diabetes and mechanism thereof: experiment with non-obese diabetic mice].
    Zhang S, Yan X, Zhou PC, Huang C, Yang L, Li X, Lin J, Zhou ZG.
    Zhonghua Yi Xue Za Zhi; 2008 Feb 26; 88(8):568-72. PubMed ID: 18649776
    [Abstract] [Full Text] [Related]

  • 19. Transfer of autoimmune diabetes from diabetic NOD mice to NOD athymic nude mice: the roles of T cell subsets in the pathogenesis.
    Matsumoto M, Yagi H, Kunimoto K, Kawaguchi J, Makino S, Harada M.
    Cell Immunol; 1993 Apr 15; 148(1):189-97. PubMed ID: 8098666
    [Abstract] [Full Text] [Related]

  • 20. Combination therapy with low dose sirolimus and tacrolimus is synergistic in preventing spontaneous and recurrent autoimmune diabetes in non-obese diabetic mice.
    Shapiro AM, Suarez-Pinzon WL, Power R, Rabinovitch A.
    Diabetologia; 2002 Feb 15; 45(2):224-30. PubMed ID: 11935154
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.